557 related articles for article (PubMed ID: 27125739)
1. Klotho and the Growth Hormone/Insulin-Like Growth Factor 1 Axis: Novel Insights into Complex Interactions.
Rubinek T; Modan-Moses D
Vitam Horm; 2016; 101():85-118. PubMed ID: 27125739
[TBL] [Abstract][Full Text] [Related]
2. The Longevity Hormone Klotho is a New Player in the Interacion of the Growth Hormone/Insulin-Like Growth Factor 1 Axis.
Rubinek T; Wolf I; Modan-Moses D
Pediatr Endocrinol Rev; 2016 Sep; 14(1):9-18. PubMed ID: 28508612
[TBL] [Abstract][Full Text] [Related]
3. The aging suppressor klotho: a potential regulator of growth hormone secretion.
Shahmoon S; Rubinfeld H; Wolf I; Cohen ZR; Hadani M; Shimon I; Rubinek T
Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E326-34. PubMed ID: 24939736
[TBL] [Abstract][Full Text] [Related]
4. Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values?
Kohler S; Tschopp O; Sze L; Neidert M; Bernays RL; Spanaus KS; Wiesli P; Schmid C
Gen Comp Endocrinol; 2013 Jul; 188():282-7. PubMed ID: 23648743
[TBL] [Abstract][Full Text] [Related]
5. Klotho response to treatment with growth hormone and the role of IGF-I as a mediator.
Rubinek T; Shahmoon S; Shabtay-Orbach A; Ben Ami M; Levy-Shraga Y; Mazor-Aronovitch K; Yeshayahu Y; Doolman R; Hemi R; Kanety H; Wolf I; Modan-Moses D
Metabolism; 2016 Nov; 65(11):1597-1604. PubMed ID: 27733247
[TBL] [Abstract][Full Text] [Related]
6. A transgenic model to determine the physiological role of liver-derived insulin-like growth factor I.
Sjögren K; Jansson JO; Isaksson OG; Ohlsson C
Minerva Endocrinol; 2002 Dec; 27(4):299-311. PubMed ID: 12511852
[TBL] [Abstract][Full Text] [Related]
7. Excessively high soluble Klotho in patients with acromegaly.
Sze L; Bernays RL; Zwimpfer C; Wiesli P; Brändle M; Schmid C
J Intern Med; 2012 Jul; 272(1):93-7. PubMed ID: 22452701
[TBL] [Abstract][Full Text] [Related]
8. The Complex World of Regulation of Pituitary Growth Hormone Secretion: The Role of Ghrelin, Klotho, and Nesfatins in It.
Devesa J
Front Endocrinol (Lausanne); 2021; 12():636403. PubMed ID: 33776931
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone and Klotho.
Schmid C; Neidert MC; Tschopp O; Sze L; Bernays RL
J Endocrinol; 2013 Nov; 219(2):R37-57. PubMed ID: 24096965
[TBL] [Abstract][Full Text] [Related]
10. Insights into a role of GH secretagogues in reversing the age-related decline in the GH/IGF-I axis.
Frutos MG; Cacicedo L; Fernández C; Vicent D; Velasco B; Zapatero H; Sánchez-Franco F
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1140-52. PubMed ID: 17684105
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone and a partial mediator of its biological action, insulin-like growth factor I.
Pankov YA
Biochemistry (Mosc); 1999 Jan; 64(1):1-7. PubMed ID: 9986906
[TBL] [Abstract][Full Text] [Related]
12. Regulation of growth hormone (GH) gene expression and secretion during pregnancy and lactation in the rat: role of insulin-like growth factor-I, somatostatin, and GH-releasing hormone.
Escalada J; Sánchez-Franco F; Velasco B; Cacicedo L
Endocrinology; 1997 Aug; 138(8):3435-43. PubMed ID: 9231798
[TBL] [Abstract][Full Text] [Related]
13. Hypothalamic/pituitary-axis of the spontaneous dwarf rat: autofeedback regulation of growth hormone (GH) includes suppression of GH releasing-hormone receptor messenger ribonucleic acid.
Kamegai J; Unterman TG; Frohman LA; Kineman RD
Endocrinology; 1998 Aug; 139(8):3554-60. PubMed ID: 9681507
[TBL] [Abstract][Full Text] [Related]
14. Influences of the environment on the endocrine and paracrine fish growth hormone-insulin-like growth factor-I system.
Reinecke M
J Fish Biol; 2010 Apr; 76(6):1233-54. PubMed ID: 20537012
[TBL] [Abstract][Full Text] [Related]
15. Does the GH/IGF-1 axis contribute to skeletal sexual dimorphism? Evidence from mouse studies.
Liu Z; Mohan S; Yakar S
Growth Horm IGF Res; 2016 Apr; 27():7-17. PubMed ID: 26843472
[TBL] [Abstract][Full Text] [Related]
16. A model for tissue-specific inducible insulin-like growth factor-I (IGF-I) inactivation to determine the physiological role of liver-derived IGF-I.
Sjögren K; Jansson JO; Isaksson OG; Ohlsson C
Endocrine; 2002 Dec; 19(3):249-56. PubMed ID: 12624424
[TBL] [Abstract][Full Text] [Related]
17. Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly.
Kovacs M; Kineman RD; Schally AV; Zarandi M; Groot K; Frohman LA
Endocrinology; 1997 Nov; 138(11):4536-42. PubMed ID: 9348175
[TBL] [Abstract][Full Text] [Related]
18. Human aging and the GH-IGF-I axis.
Ghigo E; Arvat E; Gianotti L; Ramunni J; DiVito L; Maccagno B; Grottoli S; Camanni F
J Pediatr Endocrinol Metab; 1996 Jun; 9 Suppl 3():271-8. PubMed ID: 8887170
[TBL] [Abstract][Full Text] [Related]
19. Autofeedback suppression of growth hormone (GH) secretion in transgenic mice expressing a human GH reporter targeted by tyrosine hydroxylase 5'-flanking sequences to the hypothalamus.
Szabo M; Butz MR; Banerjee SA; Chikaraishi DM; Frohman LA
Endocrinology; 1995 Sep; 136(9):4044-8. PubMed ID: 7649113
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone, insulin-like growth factors, and the skeleton.
Giustina A; Mazziotti G; Canalis E
Endocr Rev; 2008 Aug; 29(5):535-59. PubMed ID: 18436706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
